CANC Tema Oncology ETF
Issuer
Tema
Inception
Aug 14, 2023
AUM
$210.2M
Expense ratio
0.99%
Yield
0.05%
Asset class
Equity
Holdings
56
Last price
$40.54
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
+24.2%
2025-11-13low 32.81 · high 45.242026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| CANC | +3.3% | -4.7% | +16.8% | +23.6% | +22.4% | +10.6% |
| Equity average (4725 funds) | -2.2% | -4.7% | +3008.3% | +1886.0% | +15.1% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$76K net.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | GMAB GENMAB A/S | 5.83% |
| 2 | LLY ELI LILLY & CO | 5.52% |
| 3 | RVMD REVOLUTION MEDICINES INC | 5.44% |
| 4 | MRK MERCK & CO INC | 4.98% |
| 5 | COGT COGENT BIOSCIENCES INC | 4.37% |
| 6 | ONC BEONE MEDICINES LTD | 4.31% |
| 7 | NOVN.SW NOVARTIS AG | 4.20% |
| 8 | ABBV ABBVIE INC | 3.85% |
| 9 | EXEL EXELIXIS INC | 3.77% |
| 10 | RHHBY ROCHE HOLDING AG | 3.21% |
| 11 | BBIO BRIDGEBIO PHARMA INC | 3.18% |
| 12 | HALO HALOZYME THERAPEUTICS INC | 3.02% |
| 13 | BMY BRISTOL-MYERS SQUIBB CO | 2.72% |
| 14 | ELVN ENLIVEN THERAPEUTICS INC | 2.72% |
| 15 | CGON CG ONCOLOGY INC | 2.71% |
| 16 | AZN.L ASTRAZENECA PLC | 2.39% |
| 17 | JNJ JOHNSON & JOHNSON | 2.38% |
| 18 | IDYA IDEAYA BIOSCIENCES INC | 2.23% |
| 19 | RLAY RELAY THERAPEUTICS INC | 2.23% |
| 20 | IMNM IMMUNOME INC | 2.13% |
| 21 | ERAS ERASCA INC | 2.07% |
| 22 | AMGN AMGEN INC | 2.01% |
| 23 | ZLAB ZAI LAB LTD | 1.94% |
| 24 | LEGN LEGEND BIOTECH CORP | 1.83% |
| 25 | IOVA IOVANCE BIOTHERAPEUTICS INC | 1.68% |
| 26 | SMMT SUMMIT THERAPEUTICS INC | 1.56% |
| 27 | CELC CELCUITY INC | 1.37% |
| 28 | ZYME ZYMEWORKS INC | 1.31% |
| 29 | REPL REPLIMUNE GROUP INC | 1.19% |
| 30 | GILD GILEAD SCIENCES INC | 1.05% |
| 31 | GH GUARDANT HEALTH INC | 0.86% |
| 32 | NUVB NUVATION BIO INC | 0.84% |
| 33 | RCUS ARCUS BIOSCIENCES INC | 0.77% |
| 34 | CRVS CORVUS PHARMACEUTICALS INC | 0.76% |
| 35 | NTRA NATERA INC | 0.72% |
| 36 | URGN UROGEN PHARMA LTD | 0.68% |
| 37 | IMCR IMMUNOCORE HOLDINGS PLC | 0.68% |
| 38 | KURA KURA ONCOLOGY INC | 0.68% |
| 39 | INBX INHIBRX BIOSCIENCES INC | 0.62% |
| 40 | VSTM VERASTEM INC | 0.53% |
| 41 | ANL ADLAI NORTYE GROUP LTD | 0.52% |
| 42 | IBRX IMMUNITYBIO INC | 0.49% |
| 43 | ORIC ORIC PHARMACEUTICALS INC | 0.47% |
| 44 | CANC CASH & CASH EQUIVALENTS | 0.46% |
| 45 | IMTX IMMATICS NV | 0.46% |
| 46 | TNGX TANGO THERAPEUTICS INC | 0.45% |
| 47 | ANAB ANAPTYSBIO INC | 0.43% |
| 48 | CADL CANDEL THERAPEUTICS INC | 0.36% |
| 49 | OLMA OLEMA PHARMACEUTICALS INC | 0.31% |
| 50 | JANX JANUX THERAPEUTICS INC | 0.31% |
| 51 | CGEM CULLINAN THERAPEUTICS INC | 0.30% |
| 52 | TYRA TYRA BIOSCIENCES INC | 0.28% |
| 53 | CTMX CYTOMX THERAPEUTICS INC | 0.25% |
| 54 | ARVN ARVINAS INC | 0.21% |
| 55 | BCAX BICARA THERAPEUTICS INC | 0.19% |
| 56 | AUTL AUTOLUS THERAPEUTICS PLC | 0.16% |
Sector breakdown
Healthcare100.0%
Country breakdown
United States82.5%
Switzerland7.3%
Denmark5.9%
United Kingdom2.3%
China1.9%
Distributions
| Date | Per unit |
|---|---|
| Dec 10, 2025 | $0.0196 |
| Dec 11, 2024 | $0.7283 |
| Dec 13, 2023 | $0.1491 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in CANC in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error